HBIS Group saw the highest growth of 151% in patent filings and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 151% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of HBIS Group’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

HBIS Group has been focused on protecting inventions in China(CN) with 40 publications in Q4 2023

The China(CN) Patent Office dominates the patent filings and grants with nearly 97% filings and 83% grants. The China(CN), World Intellectual Property Organization(WIPO), and Luxembourg(LU) patent Office are among the top ten patent offices where HBIS Group is filings its patents. Among the top granted patent authorities, HBIS Group has 83% of its grants in China(CN) and 17% in Luxembourg(LU).

Patents related to artificial intelligence and robotics lead HBIS Group's portfolio

HBIS Group has the highest number of patents in artificial intelligence followed by, robotics. For artificial intelligence, nearly 50% of patents were filed and no patents were granted in Q4 2023.

For comprehensive analysis of HBIS Group's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.